Variant report
Variant | nsv979836 |
---|---|
Chromosome Location | chr3:54659941-54661074 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:13)
- CpG islands (count:305)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:13 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | E2F6 | chr3:54661046-54661748 | H1-hESC | embryonic stem cell: | n/a | n/a |
2 | GTF2F1 | chr3:54660804-54660940 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | POLR2A | chr3:54660743-54660937 | H1-hESC | embryonic stem cell: | n/a | n/a |
4 | POLR2A | chr3:54660237-54660643 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | POLR2A | chr3:54660181-54660688 | GM12892 | blood: | n/a | n/a |
6 | POLR2A | chr3:54660269-54660539 | GM12892 | blood: | n/a | n/a |
7 | POLR2A | chr3:54660257-54660667 | H1-hESC | embryonic stem cell: | n/a | n/a |
8 | POLR2A | chr3:54660701-54668630 | H1-hESC | embryonic stem cell: | n/a | n/a |
9 | POLR2A | chr3:54660715-54668675 | H1-hESC | embryonic stem cell: | n/a | n/a |
10 | POLR2A | chr3:54660423-54660494 | H1-hESC | embryonic stem cell: | n/a | n/a |
11 | POLR2A | chr3:54660195-54670208 | H1-hESC | embryonic stem cell: | n/a | n/a |
12 | STAT3 | chr3:54660000-54660005 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | ZBTB33 | chr3:54660267-54660763 | K562 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:54659987-54660037 | AG09309 | skin: | n/a |
2 | chr3:54660332-54660382 | HRPEpiC | eye: | n/a |
3 | chr3:54660332-54660382 | HL-60 | blood: | n/a |
4 | chr3:54660332-54660382 | HUVEC | blood vessel: | n/a |
5 | chr3:54660934-54660984 | HCM | heart: | n/a |
6 | chr3:54660532-54660582 | HepG2 | liver: | n/a |
7 | chr3:54660332-54660382 | HCF | heart: | n/a |
8 | chr3:54659987-54660037 | HCF | heart: | n/a |
9 | chr3:54660934-54660984 | HMEC | breast: | n/a |
10 | chr3:54660438-54660488 | MCF10A-Er-Src | breast: | n/a |
11 | chr3:54660438-54660488 | NHDF-neo | bronchial: | n/a |
12 | chr3:54659987-54660037 | HCM | heart: | n/a |
13 | chr3:54660532-54660582 | BE2_C | brain: | n/a |
14 | chr3:54660532-54660582 | Hela-S3 | cervix: | n/a |
15 | chr3:54659987-54660037 | GM12891 | blood: | n/a |
16 | chr3:54660934-54660984 | LNCaP | prostate: | n/a |
17 | chr3:54660438-54660488 | GM19239 | blood: | n/a |
18 | chr3:54660332-54660382 | HRE | kidney: | n/a |
19 | chr3:54660532-54660582 | GM12878 | blood: | n/a |
20 | chr3:54660934-54660984 | HEEpiC | esophagus: | n/a |
21 | chr3:54660934-54660984 | ECC-1 | luminal epithelium: | n/a |
22 | chr3:54660532-54660582 | HMEC | breast: | n/a |
23 | chr3:54660532-54660582 | HCF | heart: | n/a |
24 | chr3:54659987-54660037 | HNPCEpiC | eye: | n/a |
25 | chr3:54660332-54660382 | NB4 | blood: | n/a |
26 | chr3:54660332-54660382 | K562 | blood: | n/a |
27 | chr3:54660532-54660582 | MCF-7 | breast: | n/a |
28 | chr3:54660532-54660582 | GM12891 | blood: | n/a |
29 | chr3:54660332-54660382 | HAEpiC | amniotic membrane: | n/a |
30 | chr3:54659987-54660037 | ECC-1 | luminal epithelium: | n/a |
31 | chr3:54660332-54660382 | MCF10A-Er-Src | breast: | n/a |
32 | chr3:54660332-54660382 | ProgFib | skin: | n/a |
33 | chr3:54660332-54660382 | HepG2 | liver: | n/a |
34 | chr3:54660438-54660488 | Hepatocyte | liver: | n/a |
35 | chr3:54660934-54660984 | GM12878 | blood: | n/a |
36 | chr3:54660438-54660488 | HepG2 | liver: | n/a |
37 | chr3:54660438-54660488 | ECC-1 | luminal epithelium: | n/a |
38 | chr3:54660438-54660488 | CMK | blood: | n/a |
39 | chr3:54660934-54660984 | Hepatocyte | liver: | n/a |
40 | chr3:54659987-54660037 | SK-N-MC | brain: | n/a |
41 | chr3:54660438-54660488 | AoSMC | blood vessel: | n/a |
42 | chr3:54660332-54660382 | AoSMC | blood vessel: | n/a |
43 | chr3:54659987-54660037 | LNCaP | prostate: | n/a |
44 | chr3:54660934-54660984 | GM06990 | blood: | n/a |
45 | chr3:54659987-54660037 | RPTEC | kidney: | n/a |
46 | chr3:54660438-54660488 | ovcar-3 | ovarian: | n/a |
47 | chr3:54660332-54660382 | Hepatocyte | liver: | n/a |
48 | chr3:54660438-54660488 | Jurkat | blood: | n/a |
49 | chr3:54660532-54660582 | GM06990 | blood: | n/a |
50 | chr3:54660332-54660382 | AG04449 | skin: | fetal |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RPS15P5 | TF binding region |
RPS15P5 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs116068882 | chr3:54659987-54659988 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs544694434 | chr3:54659991-54659992 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs193135069 | chr3:54660006-54660007 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs202170390 | chr3:54660014-54660015 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs537962335 | chr3:54660020-54660021 | Weak transcription Enhancers | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs2030396 | chr3:54660089-54660090 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs561456625 | chr3:54660109-54660110 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs530396638 | chr3:54660122-54660123 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs77875113 | chr3:54660135-54660136 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs570055767 | chr3:54660138-54660139 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs532504945 | chr3:54660147-54660148 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs552705132 | chr3:54660185-54660186 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs568177643 | chr3:54660226-54660227 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs145134095 | chr3:54660235-54660236 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs147586179 | chr3:54660266-54660267 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs141786838 | chr3:54660269-54660270 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs567479259 | chr3:54660275-54660276 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs595993 | chr3:54660276-54660277 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs111356988 | chr3:54660279-54660280 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs557539755 | chr3:54660320-54660321 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs188367726 | chr3:54660343-54660344 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs558391813 | chr3:54660358-54660359 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs191268956 | chr3:54660402-54660403 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs541291856 | chr3:54660420-54660421 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs561529493 | chr3:54660424-54660425 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs530366958 | chr3:54660457-54660458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs577713702 | chr3:54660458-54660459 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs595040 | chr3:54660469-54660470 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs62255536 | chr3:54660472-54660473 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs552569211 | chr3:54660475-54660476 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs150029814 | chr3:54660496-54660497 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs369007839 | chr3:54660500-54660501 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs547324482 | chr3:54660514-54660515 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs567448478 | chr3:54660518-54660519 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs536001608 | chr3:54660532-54660533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs556042737 | chr3:54660544-54660545 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs569587897 | chr3:54660600-54660601 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs183753629 | chr3:54660622-54660623 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs558502879 | chr3:54660623-54660624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs572091195 | chr3:54660626-54660627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs541111110 | chr3:54660631-54660632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs554326817 | chr3:54660633-54660634 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs375291671 | chr3:54660664-54660665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs56209938 | chr3:54660686-54660687 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
45 | rs3198481 | chr3:54660706-54660707 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs1135664 | chr3:54660709-54660710 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs147481753 | chr3:54660712-54660713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs544001071 | chr3:54660726-54660727 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs56012825 | chr3:54660727-54660728 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs71096430 | chr3:54660735-54660736 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Breast cancer | 21785460 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16608533 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21509527 | CNVD |
Prostate cancer | 18632612 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Breast cancer | 19490591 | CNVD |
Autism | 18414403 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Metastatic melanoma | 17975146 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:54651000-54666400 | Weak transcription | H9 Cell Line | embryonic stem cell |
2 | chr3:54652800-54665000 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
3 | chr3:54654000-54667000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr3:54654800-54662400 | Weak transcription | Right Atrium | heart |
5 | chr3:54655000-54662400 | Weak transcription | Stomach Smooth Muscle | stomach |
6 | chr3:54655600-54662800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
7 | chr3:54658800-54662800 | Weak transcription | Ovary | ovary |
8 | chr3:54659200-54664600 | Weak transcription | Fetal Muscle Leg | muscle |
9 | chr3:54659800-54660400 | Enhancers | Esophagus | oesophagus |
10 | chr3:54659800-54662800 | Weak transcription | Brain Anterior Caudate | brain |
11 | chr3:54659800-54664400 | Weak transcription | Spleen | Spleen |
12 | chr3:54660400-54663000 | Weak transcription | Esophagus | oesophagus |
13 | chr3:54660400-54666800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |